Oncolix Sponsors Additional Research with MD Anderson Cancer Center
January 31, 2018 07:30 ET | Oncolix
HOUSTON, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Oncolix, Inc., (OTCQB:ONCX) announced today that the Company has sponsored additional research with MD Anderson Cancer Center. The research will evaluate...
Oncolix Initiates Patient Recruitment of Second Cohort of Prolanta™ Phase 1 Trial in Advanced Ovarian Cancer
January 08, 2018 07:00 ET | Oncolix
HOUSTON, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Oncolix, Inc., (OTCQB:ONCX) announced today that the Company’s clinical site investigator has initiated patient recruitment for the second dosing group for...
Oncolix, Inc., Announces Approval for Listing on OTC-QB
December 18, 2017 16:10 ET | Oncolix
HOUSTON, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Oncolix, Inc., (OTC PINK:ONCX) announced today that the Company has been given approval by the OTC Markets to be listed and traded on the OTC-QB effective...
Oncolix, Inc., Announces Submission of Application for Listing on OTC-QB
December 06, 2017 07:30 ET | Oncolix
HOUSTON, Dec. 06, 2017 (GLOBE NEWSWIRE) -- Oncolix, Inc., (OTC PINK:ONCX) announced today that following the appointment of the second independent member of the Board of Directors the Company has...
Oncolix, Inc. Expands Board of Directors with New Appointment
December 04, 2017 07:30 ET | Oncolix
HOUSTON, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Oncolix, Inc. (OTC PINK:ONCX) (the “Company”), a biotechnology company focused on gynecological cancers, announced the appointment of John W. Holaday,...
A Personal Letter to the Shareholders from Michael T. Redman, CEO of Oncolix, Inc.
November 29, 2017 07:30 ET | Oncolix
HOUSTON, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Oncolix, Inc., (OTC PINK:ONCX) a company focused on developing new cancer therapeutics, announces a letter from the CEO. My fellow shareholders, First, I...
UPDATE -- Oncolix, Inc. is the New Name of Advanced Environmental Petroleum Producers to Reflect Company’s Focus as a Clinical-Stage Oncology Biopharmaceutical Company
October 04, 2017 13:30 ET | Oncolix
HOUSTON, Oct. 04, 2017 (GLOBE NEWSWIRE) -- Advanced Environmental Petroleum Producers Inc. (OTC PINK:AEPP) announced that it has changed its name to Oncolix, Inc., to reflect its focus on developing...
Oncolix Appoints Two Members to Its Board of Directors
October 04, 2017 08:49 ET | Oncolix
Board Members bring Clinical and Manufacturing Expertise to Clinical-Stage Biopharmaceutical Company Independent Board Member Appointment Step toward NASDAQ Listing Objective HOUSTON, Oct. 04, 2017...
Oncolix, Inc. is the New Name of Advanced Environmental Petroleum Producers to Reflect Company’s Focus as a Clinical-Stage Oncology Biopharmaceutical Company
October 03, 2017 08:00 ET | Oncolix
HOUSTON, Oct. 03, 2017 (GLOBE NEWSWIRE) -- (AEPP) Advanced Environmental Petroleum Producers Inc. announced that it has changed its name to Oncolix, Inc., to reflect its focus on developing new...
AEPP Announces Proposed Name Change to Oncolix, Inc.
August 22, 2017 11:43 ET | Oncolix
HOUSTON, Aug. 22, 2017 (GLOBE NEWSWIRE) -- AEPP, a Houston-based biotechnology company focused on gynecological cancers, today announced it intends to change its name to Oncolix, Inc.  The new name...